A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation
Purvesh Khatri(Stanford University), Minnie Sarwal(Stanford University), Naoyuki Kimura(Cardiovascular Institute of the South), Maarten Naesens(KU Leuven), Atul J. Butte(University of California, San Francisco), Silke Roedder(Lucile Packard Children's Hospital), Yongquan Gong(Cardiovascular Institute of the South), Alexander A. Morgan(Cardiovascular Institute of the South), Michael P. Fischbein(Stanford Medicine), Robert C. Robbins(Harry S. Truman Memorial Veterans' Hospital), Katrien De Vusser(KU Leuven)
Cited by 231
Related Papers
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k
Systematic pan-cancer analysis of tumour purity
|Nature Communications|2015|1.3k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809